Stay updated on Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study record remains unavailable, now displaying “TypeError: Failed to fetch” instead of a 403 error. The NIH transition notice is no longer displayed.SummaryDifference1%

- Check18 days agoChange DetectedThe footer’s site revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA sitewide banner announces NIH website updates and notes that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check38 days agoChange DetectedThe displayed site revision changed from v3.7.0 to v3.7.1 on the error page. The study record remains inaccessible.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now shows a 403 Forbidden error page instead of the study record details, indicating an access restriction or site issue rather than a content update.SummaryDifference19%

Stay in the know with updates to Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial page.